Incyte Corporation
71.90
-0.47 (-0.65%)
At close: Jan 14, 2025, 3:59 PM
73.60
2.36%
Pre-market Jan 15, 2025, 04:28 AM EST

Incyte Corporation Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Sep 30, 2012Dec 31, 2011
I C L U S I G Revenue 29.75M 26.86M 30.34M 27.72M 29.09M 27.68M 27.62M 25.93M 26.22M 26.07M 0 28.52M 28.19M 25.64M 110.00M 26.38M 22.80M 27.25M 0 20.61M 24.39M 20.64M 60.00M 20.10M 19.90M 20.80M 182.00M 106.00M 72.80M 43.30M 9.00M 2.00M
I C L U S I G Revenue Growth +10.73% -11.47% +9.46% -4.70% +5.06% +0.25% +6.51% -1.12% +0.59% n/a -100.00% +1.18% +9.92% -76.69% +316.98% +15.71% -16.33% n/a -100.00% -15.50% +18.18% -65.60% +198.51% +1.01% -4.33% -88.57% +71.70% +45.60% +68.13% +381.11% +350.00% n/a
J A K A F I Revenue 115.74M 99.32M 89.59M 732.80M 772.83M 656.66M 738.68M 705.40M 681.38M 615.33M 0 642.03M 611.09M 531.31M n/a 556.09M 539.92M 515.81M n/a 491.83M 466.40M 421.18M n/a 398.50M 392.70M 313.70M n/a n/a n/a n/a n/a n/a
J A K A F I Revenue Growth +16.54% +10.85% -87.77% -5.18% +17.69% -11.10% +4.72% +3.53% +10.73% n/a -100.00% +5.06% +15.02% n/a n/a +2.99% +4.67% n/a n/a +5.45% +10.74% n/a n/a +1.48% +25.18% n/a n/a n/a n/a n/a n/a n/a
M I N J U V I Revenue 31.44M 31.12M 23.87M 8.35M 13.16M 6.56M 4.81M 5.93M 4.41M 4.50M 67.97M 556.00K 10.00M 32.26M n/a 95.00M 95.00M 25.45M n/a 17.50M 20.00M 40.00M n/a 20.00M 100.00M n/a n/a n/a n/a n/a n/a n/a
M I N J U V I Revenue Growth +1.04% +30.33% +185.98% -36.56% +100.72% +36.33% -18.93% +34.48% -2.02% -93.38% +12125.72% -94.44% -69.00% n/a n/a 0.00% +273.32% n/a n/a -12.50% -50.00% n/a n/a -80.00% n/a n/a n/a n/a n/a n/a n/a n/a
Milestone And Contract Revenue Revenue 18.00M 0 25.00M 29.61M 32.01M 0 160.00M 20.37M 16.56M 5.00M 50.00M 35.00M 36.05M 13.46M n/a 28.65M 25.83M n/a n/a 21.64M 19.14M 16.04M n/a 11.00M 8.90M n/a n/a n/a n/a n/a n/a n/a
Milestone And Contract Revenue Revenue Growth n/a -100.00% -15.58% -7.48% n/a -100.00% +685.43% +23.01% +231.20% -90.00% +42.86% -2.90% +167.87% n/a n/a +10.91% n/a n/a n/a +13.08% +19.35% n/a n/a +23.60% n/a n/a n/a n/a n/a n/a n/a n/a
Olumiant Royalty Revenue 34.80M 31.70M 30.59M 91.84M 80.23M 34.16M 114.18M 38.14M 18.98M 12.75M 66.00M 86.57M 17.91M 2.05M n/a 8.09M 3.79M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Olumiant Royalty Revenue Growth +9.76% +3.64% -66.69% +14.46% +134.91% -70.09% +199.36% +100.92% +48.84% -80.68% -23.76% +383.48% +774.74% n/a n/a +113.66% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
OPZELURA Revenue 139.27M 121.69M 85.72M 19.46M 21.92M 56.55M 61.28M 23.41M 3.58M 18.03M 60.47M 17.56M 2.48M n/a n/a 1.44M 706.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
OPZELURA Revenue Growth +14.44% +41.96% +340.40% -11.20% -61.24% -7.72% +161.73% +553.84% -80.14% -70.18% +244.33% +609.29% n/a n/a n/a +103.68% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PEMAZYRE Royalty Revenues Revenue 21.07M 21.14M 18.22M 4.14M 4.80M 22.89M 24.22M 4.11M n/a 3.48M 3.12M 2.75M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
PEMAZYRE Royalty Revenues Revenue Growth -0.33% +16.03% +340.30% -13.75% -79.03% -5.51% +488.75% n/a n/a +11.67% +13.54% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Tabrecta Royalty Revenues Revenue 5.93M 5.30M 5.23M 98.00K 570.00K 4.18M 4.23M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Tabrecta Royalty Revenues Revenue Growth +11.89% +1.22% +5240.82% -82.81% -86.35% -1.32% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
ZYNYZ Revenue 694.00K 651.00K 467.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
ZYNYZ Revenue Growth +6.61% +39.40% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Europe Revenue 147.00M 124.10M 105.00M 90.00M 79.90M 66.90M 29.60M
Europe Revenue Growth +18.45% +18.19% +16.67% +12.64% +19.43% +126.01% n/a
United States Revenue 3.20B n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 309.20M 289.63M 300.30M 293.90M 267.89M 283.90M 315.61M 272.82M 266.50M 253.28M 209.58M 226.20M 190.70M 168.90M 153.79M 166.99M 120.80M 118.00M 111.15M 136.18M 102.61M 105.94M 123.98M 108.36M 96.52M 108.03M 121.50M 97.83M 91.27M 90.07M 87.23M 96.08M 75.78M 66.79M 64.60M 52.47M 47.60M 51.68M 44.87M
Selling, General, and Administrative Revenue Growth +6.76% -3.55% +2.18% +9.71% -5.64% -10.05% +15.68% +2.37% +5.22% +20.85% -7.35% +18.62% +12.91% +9.82% -7.90% +38.24% +2.37% +6.16% -18.38% +32.72% -3.15% -14.55% +14.42% +12.26% -10.65% -11.09% +24.19% +7.19% +1.33% +3.25% -9.21% +26.80% +13.45% +3.40% +23.12% +10.23% -7.89% +15.17% n/a
Research and Development Revenue 573.17M 1.14B 429.26M 444.49M 375.71M 400.75M 406.64M 501.36M 384.01M 347.20M 353.37M 472.83M 334.94M 343.51M 306.90M 405.94M 438.11M 286.60M 1.09B 312.87M 281.34M 289.36M 270.55M 304.24M 292.53M 298.09M 303.10M 446.94M 269.61M 201.84M 407.97M 161.59M 143.18M 120.27M 156.82M 116.63M 132.07M 112.44M 118.36M
Research and Development Revenue Growth -49.65% +165.20% -3.43% +18.31% -6.25% -1.45% -18.89% +30.56% +10.60% -1.75% -25.26% +41.17% -2.49% +11.93% -24.40% -7.34% +52.86% -73.59% +246.88% +11.21% -2.77% +6.96% -11.07% +4.00% -1.87% -1.65% -32.18% +65.77% +33.58% -50.53% +152.48% +12.85% +19.05% -23.31% +34.46% -11.69% +17.46% -5.00% n/a